w w w . j c o l . o r g . b r
Journal
of
Coloproctology
Original
Article
Effects
of
hydroalcoholic
extract
of
Ziziphus
jujuba
on
acetic
acid
induced
ulcerative
colitis
in
male
rat
(
Rattus
norvegicus
)
Nader
Tanideh
a,b,
Akram
Jamshidzadeh
c,
Ali
Ghanbari
Saghesloo
c,∗,
Farhad
Rahmanifar
d,
Maral
Mokhtari
e,
Omid
Koohi-Hosseinabadi
f,
Mahmood
Omidi
c,
Asma
Najibi
caShirazUniversityofMedicalSciences,StemCellandTransgenicTechnologyResearchCenter,Shiraz,Iran bShirazUniversityofMedicalSciences,SchoolofMedicine,DepartmentofPharmacology,Shiraz,Iran
cShirazUniversityofMedicalSciences,SchoolofPharmacy,DepartmentofPharmacologyToxicology,Shiraz,Iran dShirazUniversity,SchoolofVeterinaryMedicine,DepartmentofAnatomy,Shiraz,Iran
eShirazUniversityofMedicalSciences,SchoolofMedicine,DepartmentofPathology,Shiraz,Iran fShirazUniversityofMedicalSciences,CenterofComparativeandExperimentalMedicine,Shiraz,Iran
a
r
t
i
c
l
e
i
n
f
o
Articlehistory:
Received1March2016 Accepted20April2016 Availableonline27May2016
Keywords: Ziziphusjujuba
Ulcerativecolitis Oxidativestress Histopathology Inflammation
a
b
s
t
r
a
c
t
Objective:To investigate the effects of hydroalcoholic extract of Ziziphus jujuba on the histopathological,tissueoxidativestressandinflammationplustoantioxidantpathways ofcolontissueinratwithinducedUlcerativecolitis.
Materialsandmethods:Ulcerativecolitiswasinducedin80ratsthosedividedinto8equal groups.Group1and2werenegativecontrolsreceiving1mL/dayofnormalsalineinenema and oral; group3 and 4as positive control1 and 2received 10mg/kg of intra-colonic asacolandoralmesalazine;groups5and6received20%and40%ofhydroalcoholicextract
ofZ.jujubatrans-rectally;group7and8received1500and3000mg/kgofhydroalcoholic extractofZ.jujubaorally,respectively.After7days,animalswereevaluatedforcolontissue histopathology,levelsofmalondialdehydeandIL-1,andactivitiesofsuperoxidedismutase, glutathioneperoxidaseandmyeloperoxidaseincolontissue.
Results:HydroalcoholicextractofZ.jujubainbothformsoftrans-rectalandoral adminis-trationespeciallyinthehigherdosescouldresultintoamorehealingeffectindamaged colonictissue,morereduceglutathioneperoxidaseandIL-1level.Also,thesetwodoses (gel40%andoral3000mg/kg)couldmoredecreasethemyeloperoxidaseactivityand stimu-latesuperoxidedismutaseandglutathioneperoxidaseactivities.Also,gel40%intransrectal administrationwasmorepotentthanadministration3000mg/kginoral.
∗ Correspondingauthor.
E-mail:articlepublishers93@gmail.com(A.GhanbariSaghesloo).
http://dx.doi.org/10.1016/j.jcol.2016.04.007
Conclusion: TheresultsofthepresentstudyindicatedthatZ.jujubemaybeconsideredasa treatmentofchoiceforUlcerativecolitisespeciallyingelformandalsoindose-dependent pattern.
©2016PublishedbyElsevierEditoraLtda.onbehalfofSociedadeBrasileirade Coloproctologia.ThisisanopenaccessarticleundertheCCBY-NC-NDlicense(http:// creativecommons.org/licenses/by-nc-nd/4.0/).
Efeitos
do
extrato
hidroalcoólico
de
Ziziphus
jujuba
na
colite
ulcerativa
induzida
pelo
ácido
acético
em
rato
macho
(
Rattus
norvegicus
)
Palavras-chave: Ziziphusjujuba
Coliteulcerativa Estresseoxidativo Histopatologia Inflamac¸ão
r
e
s
u
m
o
Objetivo: Investigar os efeitos doextrato hidroalcoólico de Ziziphus jujuba noestresse oxidativo emtecidoao nívelhistopatológicoena inflamac¸ão,juntamentecomasvias antioxidantesemtecidodecólonemratoscomcoliteulcerativainduzida.
Materiaisemétodos:Induzimoscoliteulcerativaem80ratos,divididosem8gruposiguais. Osgrupos1e2eramcontrolesnegativosquereceberam1mL/diadesalinanormalem enemaeporvia oral;osgrupos3e4eram controlespositivospara1e 2ereceberam 10mg/kgde asacol porvia intracolônicae mesalazinaoral;os grupos5e 6receberam gela20%e40%deextratohidroalcoólicodeZ.jujubaporviatrans-retal;osgrupos7e8 receberam1500e3000mg/kgdeextratohidroalcoólicodeZ.jujubaporviaoral, respectiva-mente.Transcorridos7dias,osanimaisforamavaliadosparahistopatologiadetecidode cólon,níveisdemalonildialdeídoeIL-1,eatividadesdesuperóxidodismutase,glutátion peroxidaseemieloperoxidasenotecidocolônico.
Resultados: OusodoextratohidroalcoólicodeZ.jujuba,tantonaformatransretalcomo oral,eemespecialnasdosesmaisaltas,resultouemumefeitodecicatrizac¸ãomaisintensa notecidocolônicolesionado,eemmaiorreduc¸ãonosníveisdeglutátionperoxidase IL-1.Alémdisso,essasduasdoses(gela40%e3000mg/kgporviaoral)diminuíramainda maisaatividadedemieloperoxidaseeestimularamasatividadesdesuperóxidodismutase eglutátionperoxidase.Outroachadodoestudofoiqueogela40%poradministrac¸ão trans-retalsemostroumaispotentedoqueaadministrac¸ãooralde3000mg/kg.
Conclusão: OsresultadosdopresenteestudosugeremqueZ.jujubapodeserconsiderado comotratamentodeescolhaparacoliteulcerativa,sobretudoemformadegeletambém emumpadrãoproporcionalàdoseadministrada.
©2016PublicadoporElsevierEditoraLtda.emnomedeSociedadeBrasileirade Coloproctologia.Este ´eumartigoOpenAccesssobumalicenc¸aCCBY-NC-ND(http:// creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Inflammatoryboweldiseases(IBDs)includetwoparts, ulcer-ative colitis(UC)and Crohn’sdisease(CD). UCaffected the superficiallayer ofall partsofthe large intestinespecially descendingcolon and rectum.1 IncidenceofUC is 1.2–20.3 casesanditsprevalenceis7.6–240casesper100000peoples ineachyear.2ThebasisoftheUCisgeneticallysusceptibility toinflammationandalsoenvironmentaltriggers.3These envi-ronmentalfactorsincludemicrobiological,4,5immunological,6 smokingandpsychologicalfactors.5So,sometreatmentscan be applicableto overcome these environmental factors.In addition,besidesthecostoftreatment,theimpactofUCon qualityoflifeisstaggering.7Therefore,findingeffectiveand costbenefittreatmentforUCisnecessary.
Beforeeachstudyforfindinggoodtherapeuticagentsfor UC,itisnecessarytosimulatetheconditionssimilartohuman UC inanimal models. There are several modelsfor induc-tionofUCinanimalssuchasuseoftrinitrobenzenesulfonic
acid(TNBS)(7),dextransodiumsulfate,8andaceticacid.9 Rec-tal administration ofacetic acid can mimicthe conditions which occurred inhumanUC10 and related UCis a repro-duciblelaboratoryanimalmodelandisusefulforscreening ofeffectivenessofdrugs.11
Materials
and
methods
Ethicalstatement
TheprotocolofthepresentedstudyisapprovedbytheEthical CommitteeofShirazUniversityofMedicalSciences.Allefforts weremadetopreventtheharmfulhandlingoftheanimals andalsothelowestbutstatisticallysignificantnumberofthe animalswasallocatedineachgroup.
Fruitandextraction
Z.jujubafruitswerepurchasedfrom localmarketand after genusandspeciesconfirmationbyBotanistaffiliatedto Agri-cultureSchoolofShirazUniversity,werefinelygroundedby mixer.Thehydroalcoholicextractionwasperformed accord-ing to previous report.15 The antioxidant content of this extractwasevaluatedusingferricreducingantioxidantpower (FRAP)testasdescribedpreviously.16
Animals
Inthisstudy,80 maleSprague Dawleyratswithmean and SDofweighof200±20gwerepurchasedfromtheCenterof Comparativeand Experimental Medicine,Shiraz University of Medical Sciences. They kept under conventional condi-tionsinclude22±1◦C,55±5%relativehumidity,and12/12h light/darkcyclesbeforethe onsetofthestudy for acclima-tionandduringthestudyperiod.Allratswerefastedfor24h andthenUCwasinducedbyrectaladministrationof1mLof 3%aceticacid.Animalswererandomlyallocatedinto8equal separatedgroupsandreceiveddifferenttreatmentafter24h, basedontheTable1.
Attheendofthe7thday,allratsweresacrificedby cervi-caldislocationandsamplesfromcolontissuewereobtained
Table1–Experimentalsetupandtreatmentswhich usedinthisstudy.
Groupno. Abbreviation Treatment
1 Negativecontrol1(NC1) 1mLnormalsaline, enema
2 Negativecontrol2(NC2) 1mLnormalsaline, oral
3 Positivecontrol1(PC1) Asacol10mg/kg, enema
4 Positivecontrol2(PC2) Mesalazine10mg/kg, oral
5 Gel20% 1mLofgel20%of
ZJHE,enema
6 Gel40% 1mLofgel40%of
ZJHE,enema
7 Oral1500 1mLofsolutionof
ZJHEasdose 1500mg/kg,oral
8 Oral3000 1mLofsolutionof
ZJHEasdose 3000mg/kg,oral
ZJHE,Z.jujubahydroalcoholicextract.
andfixedin10%bufferedformalin.Thetissueprocessingand histopathologicalslidepreparationwereperformedaccording to previous procedures.17–19 The histopathological sections wereevaluatedforseverityandextentofinflammation,crypt damage,percentofinvolvementandregeneration.
Measurementofmalondialdehyde(MDA)level
Briefly,500mgoftissuewashomogenizedin5mLof1.15% coldKCl.Then,3mLof1%phosphoricacidand1mLof0.6% tiobarbitoric acid were added to500lofhomogenate and shakewell.Afterindirectheatingat100◦Cfor45min,the cen-trifugationwasperformedat10000rpmfor10minand the absorbanceofthesupernatantwasmeasuredin532nmusing UV-visiblespectrophotometer.
Myeloperoxidase(MPO)activity
TwomLofphosphatebuffercontain0.5%hexadecyltrimethyl ammoniumbromide(HTAB)wasaddedto100mgofcolon tis-sueandhomogenizedoniceforsixtimesof45s.Then,10sof sonicationandfreezebyliquidnitrogenwereappliedforthree times.Centrifugationat3000rpmand4◦Cfor30minwas per-formedandsupernatantwasharvested.2.9mLofphosphate buffer containo-Dianisidineand0.005%hydrogen peroxide wasaddedto0.1mLofsupernatantandafter5min,0.1mLof 1.2MHClwasaddedtotubetoorangecolorwasappeared. Theabsorbanceofthesampleswasmeasuredat460nmby UV–visible spectrophotometer and theactivity ofMPO was calculatedusingastandardcurve.
Superoxidedismutase(SOD)andglutathioneperoxidase (GPx)activities
The activities of these two antioxidative enzymes were assessedusingcommercialkits(Biorexfars,Iran).
Interleukin(IL)-1ˇ
ThecolontissuecontentofIL-1determinedbycommercial quantitiesenzymelinkedimmunosorbent assay(ELISA)kit (Biosource,USA)accordingtothemanufacturerinstruction.
Statisticalanalysis
DatawereexpressedasmeanandSDandanalyzedusingSPSS version21.Onewayanalysisofvariance(ANOVA)withusing TukeyasPosthoctestwereusedtofindstatisticalsignificant differences (p<0.05). GraphPad 6wasusedfor drawingthe charts.
Results
a a
b b
b
Groups Inflammation severity
Deg
ree
b b
b
NC1 NC2 PC1 PC2
Gel 20% Gel 40% Oral 1500Oral 3000
4
3
2
1
0
Groups
a a
b b
b b
b b Crypt damage
Deg
ree
NC1 NC2 PC1 PC2
Gel 20% Gel 40% Oral 1500Oral 3000
5
4
3
2
1
0
a a
b b
b
Groups Extent of inflammation
Deg
ree
b b
b
NC1 NC2 PC1 PC2
Gel 20% Gel 40% Oral 1500Oral 3000
4
3
2
1
0
Groups
a a
b b
b
b b
b Percent of involvment
Deg
ree
NC1 NC2 PC1 PC2
Gel 20% Gel 40% Oral 1500Oral 3000
4
3
2
1
0
Groups
a a
b b
b b
b
b Regeneration
Deg
ree
NC1 NC2 PC1 PC2
Gel 20% Gel 40% Oral 1500Oral 3000
4
3
2
1
0
Fig.1–Comparisonofhistopathologicalindicesofdamageandregenerationbetweendifferentgroups.Significant statisticaldifferencesbetweengroupsineachindexareindicatedbydifferentsuperscriptletter(p<0.05).
all pathological indices include inflammation severity and extent,cryptdamage,percentageofinvolvementand regen-eration(p>0.05)(Fig.1).
ComparisonofMDA level as oxidativestress index and activities of two antioxidative enzymes, SOD and GPx, in colontissuearepresentedinFig.2.Asshown,thecolon tis-sue MDA concentrationin NC1 and NC2 were significantly higher than all other groups (p<0.05) but not statistically significanttogether(p>0.05).ThetissueMDAconcentration
3.0
A
B
C
2.52.0
1.5
1.0
0.5
0.0
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
1.5
1.2
0.9
0.6
0.3
0.0
a b
c c
d e
f g f
d e
e d c b a a
c
f
d
c b
a a
Groups
Concentr
ation (
µ
mol/L)
Activity (IU/L)
Activity (IU/L)
NC1 NC2 PC1 PC2
Gel 20% Gel 40% Oral 1500Oral 3000
Groups
NC1 NC2 PC1 PC2
Gel 20% Gel 40% Oral 1500Oral 3000
Groups
NC1 NC2 PC1 PC2
Gel 20% Gel 40% Oral 1500Oral 3000
Fig.2–ComparisonofmeanandSDofA,malondialdehyde level;B,glutathioneperoxidaseactivityandC,
superoxidasedismutaseactivityincolontissuesof differentexperimentalgroups.Significantstatistical differencesbetweengroupsineachindexareindicatedby differentsuperscriptletter(p<0.05).
Thisincludedhigher activitiesofenzymes inall groups in comparisontobothNCgroups,highestandlowestactivities ofbothenzymes between treatmentgroup ingel 40% and PC2,respectively, and highestactivities ofbothenzyme in responsetooralmesalazineincomparisontoenemaasacol. OtherdifferencesandtheirsignificancesareshowninFig.2B andC.
ComparisonofinflammatorybiomarkersofIL-1andMPO activity in colon tissue of different groups are presented in Fig. 3. As shown, these two inflammatory indices were
decreasedinresponsetotreatmentsincomparisontobothNC groups(p<0.05).Themostdeclineswerebelongedtothegel 40%group(210.00±22.47pg/mLforIL-1and1.19±0.05IU/L forMPO)followedbyoral3000group(318.20±31.49pg/mLfor IL-1and1.37±0.03IU/LforMPO).Othervaluesandtheir sig-nificancescanbeseeninFig.3AandB.
Discussion
In the present study antioxidative, anti-inflammatory and regenerative effects of hydroalcoholic extract of Z. jujuba
in 4 doses of 20% and 40% in gel form and enema route and 1500mg/kg and3000mg/kginoralrouteinacetic acid induced UCinrat modelwere investigated.Overall, stimu-latory effects onthe activitiesof SODand GPx, decreasing effectsonIL-1 andMDAlevelplusMPOactivity and heal-ingandregenerativeeffectsinhistopathologicalfeatureswere detected in response to use ofplant extract. Also, enema route is better than oral administration in all effects and dose-dependent response was detected in both routes of administration.
Inpreviousstudies,differentplantsandderivativeswere explored for treatment of UC. It has been reported that hydroalcoholic extract of Teucrium polium could increase healthycellsinthecolontissue,decreasetheinflammation severityandresolvetheinflammationofcolontissue.20Effects ofdifferentdosesandroutesofadministrationof hydroalco-holicextract oflicoricefor7dayintreatmentofUC inrat wereinvestigated.Itisfoundthatthesetreatmentdecreased theintestinalepitheliumdamages,TNF-␣,IL-6andNOand increasedSOD activity indose-responsepattern.21 Improv-ing ofpathological conditions ofcolon, increase ofweight anddeclineinMDAlevelwereseeninratsufferedfromUC in response to strawberry extract indose-response type.22 Similar findings are reported by our group and other sci-entists forBerberis vulgaris,23 Melilotus officinalis,9 Hypericum perforatum,24,25Calendulaofficinalis26andPistachiaatlantica27in linewithfindings ofthis study.However,the reportsabout thebeneficialeffectsofusingofZ.jujubaininflammatory dis-easesarescarce.HydroalcoholicextractofZ.jujubecanreverse oxidativestressinducedbypentylenetetrazole(PTZ)and elec-troshockinexperimentalmodelsofepilepsyinrats.28Also,the beneficialeffectshydroalcoholicextractofZ.jujubaas alterna-tivetreatmentinOMasanotherinflammatorydiseaseswas reportedbyourgrouppreviously.14
1000
A
B
a b
c c
d
e f
g
a a
b c d
e bc
f 4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0 900
800
700
600
500
400
300
200
Groups Groups
Concentr
ation (pg/mL)
Activity (IU/L)
100
0
NC1 NC2 PC1 PC2
Gel 20% Gel 40% Oral 1500Oral 3000
NC1 NC2 PC1 PC2
Gel 20% Gel 40% Oral 1500Oral 3000
Fig.3–Changesofinflammatoryindicesincolontissuesofratsindifferentgroups.A,IL-1level;B,myeloperoxidase activity.Significantstatisticaldifferencesbetweengroupsineachindexareindicatedbydifferentsuperscriptletter(p<0.05).
Conclusion
Inflammatory diseases such as UC are currently treated with steroidal and non-steroidal anti-inflammatory drugs (NSAIDs),butourfindingssuggesthydroalcoholicextractof
Z.jujubaasanewtherapeuticagentforUC.Thiscanbe con-cludedfromstimulationofhealingprocessandinhibitionof theinflammatoryandoxidativepathways.
Conflicts
of
interest
Theauthorsdeclarenoconflictsofinterest.
Acknowledgments
Authorswishtothankallstaffs ofDepartmentof Pharma-cologyToxicology,SchoolofPharmacy,ShirazUniversity of MedicalSciences,Shiraz,Iranfortheircooperationin exper-imentalprocedure and analysis. Thisarticle wasextracted fromMScThesisofMr.Ali GhanbariSaghesloowith super-vision ofDr. NaderTanideh and Dr. AkramJamshidzadeh. TheauthorsalsothanksTheArticlepublishersgroup(www. articlepublishers.ir)forkindlyhelpinarticlerevision.
r
e
f
e
r
e
n
c
e
s
1. LutgensMWMD,vanOijenMGH,vanderHeijdenGJMG, VleggaarFP,SiersemaPD,OldenburgB.Decliningriskof colorectalcancerininflammatoryboweldisease:anupdated meta-analysisofpopulation-basedcohortstudies.Inflamm BowelDis.2013;19:789–99.
2. EconomouM,ZambeliE,MichopoulosS.Incidenceand prevalenceofCrohn’sdiseaseanditsetiologicalinfluences. AnnGastroenterol.2009;22:158–67.
3. HeydarpourP,RahimianR,FakhfouriG,KhoshkishS,Fakhraei N,Salehi-SadaghianiM,etal.Behavioraldespairassociated withamousemodelofCrohn’sdisease:roleofnitricoxide pathway.ProgrNeuro-PsychopharmacolBiolPsychiatry. 2016;64:131–41.
4.PetersonJ,GargesS,GiovanniM,McInnesP,WangL,Schloss JA,etal.TheNIHhumanmicrobiomeproject.GenomeRes. 2009;19:2317–23.
5.AndreoliTE,FitzJG,BenjaminI,GriggsRC,WingEJ.Andreoli andCarpenter’sCecilessentialsofmedicine.ElsevierHealth Sciences;2010.
6.SeiboldF,BrandweinS,SimpsonS,TerhorstC,ElsonCO. pANCArepresentsacross-reactivitytoentericbacterial antigens.JClinImmunol.1998;18:153–60.
7.CromerWE,GantaCV,PatelM,TraylorJ,KevilCG,Alexander JS,etal.VEGF-AisoformmodulationinanpreclinicalTNBS modelofulcerativecolitis:protectiveeffectsofaVEGF164b therapy.JTranslMed.2013;11:207.
8.JiangX,ZhongL,SunD,RongL.MagnesiumlithospermateB actsagainstdextransodiumsulfate-inducedulcerativecolitis byinhibitingactivationoftheNRLP3/ASC/Caspase-1 pathway.EnvironToxicolPharmacol.2016;41:72–7.
9.SafarpourAR,KaviyaniF,SepehrimaneshM,AhmadiN, KoohiHosseinabadiO,TanidehN,etal.Antioxidantand anti-inflammatoryeffectsofgelandaqueousextractof MelilotusofficinalisL.ininducedulcerativecolitis:aRattus norvegicusmodel.AnnColorectRes.2015;3:e29511.
10.KandhareAD,RaygudeKS,GhoshP,GhuleAE,GosaviTP, BadoleSL,etal.EffectofhydroalcoholicextractofHibiscus rosasinensisLinn.leavesinexperimentalcolitisinrats.Asian PacJTropBiomed.2012;2:337–44.
11.BaumgartDC,CardingSR.Inflammatoryboweldisease:cause andimmunobiology.Lancet.2007;369:1627–40.
12.HuangY-L,YenG-C,SheuF,ChauC-F.Effectsofwater-soluble carbohydrateconcentratefromChinesejujubeondifferent intestinalandfecalindices.JAgricFoodChem.
2008;56:1734–9.
13.TahergorabiZ,AbediniMR,MitraM,FardMH,BeydokhtiH. Ziziphusjujuba:aredfruitwithpromisinganticancer activities.PharmacognRev.2015;9:99–106.
14.Koohi-HosseinabadiO,Andisheh-TadbirA,BahadoriP, SepehrimaneshM,MardaniM,TanidehN.Comparisonofthe therapeuticeffectsofthedietaryandtopicalformsof Zizyphusjujubaextractonoralmucositisinducedby 5-fluorouracil:agoldenhamstermodel.JClinExpDentist. 2015;7:e304–9.
15.MardaniM,AfraSM,TanidehN,AndishehTadbirA, ModarresiF,Koohi-HosseinabadiO,etal.Hydroalcoholic extractofCarumcarviL.inoralmucositis:aclinicaltrialin malegoldenhamsters.OralDis.2016;22:39–45.
16.KazemipourN,NikbinM,MaghsoudlouMT,Sepehrimanesh M.AntioxidantpropertiesofextractsofScutellaria
17.PanahiM,KarimaghaiN,RahmanifarF,TamadonA,Vahdati A,MehrabaniD,etal.Stereologicalevaluationoftestesin busulfan-inducedinfertilityofhamster.CompClinPathol. 2015;24:1051–6.
18.TamadonA,NikahvalB,SepehrimaneshM,MansourianM, NaeiniAT,NazifiS.Epididymisligation:aminimallyinvasive techniqueforpreparationofteaserrams.VetSurg.
2010;39:121–7.
19.YazdaniA,PoorbaghiSL,HabibiH,NazifiS,RahmaniFarF, SepehrimaneshM.DietaryBerberisvulgarisextractenhances intestinalmucosamorphologyinthebroilerchicken(Gallus gallus).CompClinPathol.2013;22:611–5.
20.MehrabaniD,BahramiF,HosseiniSV,AshrafMJ,TanidehN, RezaianzadehA,etal.ThehealingeffectofTeucriumpoliumin aceticacid-inducedulcerativecolitisinthedogasananimal model.MiddleEastJDigesDis.2012;4:40–7.
21.Allizadeh-NaeiniM,TanidehN,Zargari-SamadnejadA, MehrvarzS.HealingeffectofLicoriceextractinacetic acid-inducedulcerativecolitisinrat.ResPharmaceutSci. 2012;7:S837.
22.TanidehN,AkbariBaseriF,JamshidzadehA,AshrafMJ,Kuhi O,MehrabaniD.Thehealingeffectofstrawberryextracton aceticacid-inducedulcerativecolitisinrat.WorldApplSciJ. 2014;31:281–8.
23.TanidehN,AfaridiE,MehrabaniD,AzarpiraN,Hosseinzadeh M,AminiM,etal.ThehealingeffectofBerberisvulgarisin aceticacid-inducedulcerativecolitisinrat.Middle-EastJ ScientRes.2014;21:1288–94.
24.DostT,OzkayranH,GokalpF,YeniseyC,BirinciogluM.The effectofHypericumperforatum(St.John’sWort)on
experimentalcolitisinrat.DigestDisSci.2009;54: 1214–21.
25.TanidehN,NematollahiSL,HosseiniSV,HosseinzadehM, MehrabaniD,SafarpourA,etal.Thehealingeffectof Hypericumperforatumextractonaceticacid-inducedulcerative colitisinrat.AnnColorectRes.2014;2:e25188.
26.MehrabaniD,ZiaeiM,HosseiniSV,GhahramaniL, BananzadehAM,AshrafMJ,etal.TheeffectofCalendula officinalisintherapyofaceticacidinducedulcerativecolitisin dogasananimalmodel.IranRedCrescentMedJ.
2011;13:884–90.
27.TanidehN,MasoumiS,HosseinzadehM,SafarpourAR,Erjaee H,Koohi-HosseinabadiO,etal.Healingeffectofpistacia atlanticafruitoilextractinaceticacid-inducedcolitisinrats. IranJMedSci.2014;39:522–8.
28.PahujaM,MehlaJ,ReetaKH,JoshiS,GuptaYK. HydroalcoholicextractofZizyphusjujubaameliorates seizures,oxidativestress,andcognitiveimpairmentin experimentalmodelsofepilepsyinrats.EpilepsyBehav. 2011;21:356–63.
29.PravdaJ.Radicalinductiontheoryofulcerativecolitis.WorldJ Gastroenterol.2005;11:2371–84.
30.MahajanRT,ChopdaMZ.Phyto-pharmacologyofZiziphus jujubamill–aplantreview.PharmacognRev.2009;3:320–9.
31.ElalouiM,LaamouriA,FabreJ,MathieuC,VilaremG, HasnaouiB.Distributionoffreeaminoacids,polyphenols andsugarsofZiziphusjujubapulpsharvestedfromplants growninTunisia.NatProdRes.2015;29:94–7.
32.LiuJ,ChenB,YaoS.Simultaneousanalysisandidentification ofmainbioactiveconstituentsinextractofZizyphusjujuba var.sapinosa(Zizyphispinosisemen)byhigh-performance liquidchromatography–photodiodearray